Comment on 'Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19'
August 2020
in “
Journal of The American Academy of Dermatology
”
Studysummary This review critiques a study on androgenetic alopecia in hospitalized COVID-19 patients, highlighting analytical inaccuracies and suggesting that the condition's prevalence may relate to older age rather than COVID-19 infection.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This document is a letter commenting on a study that found a correlation between androgenetic alopecia (AGA) and COVID-19 severity. The authors of the letter found inaccuracies in the analysis of the study and analyzed the raw data to match AGA prevalence in the age-matched population. They found that a higher prevalence of AGA in COVID-19 patients is most likely the consequence of other factors, causing older men to be more susceptible to SARS-CoV-2 infection.
